COPENHAGEN (Thomson Financial) - H Lundbeck AS said its Lu AA21004 candidate for treating major depression disorder shows good Phase II results with "an attractive safety profile".
From: www.sharewatch.com
Lundbeck says depression treatment shows good Phase II results
Posted by Ruslan Abuzant at 7:27 AM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment